Colgate: Cost squeeze aids bottomline - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Colgate: Cost squeeze aids bottomline

Oct 23, 2002

Colgate Palmolive India (Colgate) continues with its bottomline growth led by operating efficiencies. But concerns over topline dip continue to haunt the oral care major. In September quarter, the company has reported a 10% dip in topline, but logged in a 15% growth in net profit.

(Rs m) 2QFY02 2QFY03 Change 1HFY02 1HFY03 Change
Net Sales (incl. Excise duty) 2,930 2,640 -9.9% 5,996 5,262 -12.2%
Other Income 94 58 -38.3% 165 122 -26.1%
Expenditure 2,720 2,305 -15.3% 5,560 4,624 -16.8%
Operating Profit (EBDIT) 210 335 59.5% 436 638 46.3%
Operating Profit Margin (%) 7.2% 12.7%   7.3% 12.1%  
Interest 2 1 -50.0% 4 1 -75.0%
Depreciation 40 52 30.0% 82 104 26.8%
Profit before Tax 262 340 29.8% 515 655 27.2%
Tax 97 150 54.6% 192 277 44.3%
Profit after Tax 165 190 15.2% 323 378 17.0%
Net profit margin (%) 5.6% 7.2%   5.4% 7.2%  
Effective tax rate (%) 37.0% 44.1%   37.3% 42.3%  
No. of Shares (eoy) (m) 136.0 136.0   136.0 136.0  
Diluted earnings per share* 4.9 5.6   4.8 5.6  
P/E ratio   23.8     23.9  
(* annualised)            

The reason for the 15% growth in profits is a significant improvement in operating margins (by 560 basis points). This has come about largely due to efficiencies in working capital as well as pruning of the advertising expenditure. Colgate, as we know is one of the largest advertising spenders in the FMCG segment. Its ad to sales expenses are among the highest at 19% to 21%. Its ad to sales ratio during the September quarter stood at 17.4% (as compared to 23.4% in 2QFY02).

Cost break-up
as a % of net sales 2QFY02 2QFY03 1HFY02 1HFY03
Total Cost of goods 50.9% 48.8% 52.1% 49.8%
- Staff Cost 5.3% 6.0% 5.1% 6.1%
- Advertising 23.4% 17.4% 22.4% 18.3%
- Other Expenditure 13.3% 15.1% 13.2% 13.7%

The advertising spend has declined 33% YoY during September quarter. The likely reason for this seems that buying TRP is much cheaper on a YoY basis. Also, the FMCG sector is spending more on promotions (like freebies and one for one schemes). As a result, value sales are declining, but so are advertising costs.

Though Colgate's performance is encouraging from the net profit angle, the topline continues to be a concern. The oral care market continues to stagnate at 90,000 tonnes per annum (Rs 21 bn). With both HLL and Colgate facing resistance in growing this pie, growth issues continue to haunt valuations. At Rs 133 the stock trades at 24x annualised 1HFY03 earnings, market cap to sales ratio of 1.7x.

Equitymaster requests your view! Post a comment on "Colgate: Cost squeeze aids bottomline". Click here!


More Views on News

COLGATE Announces Quarterly Results (2QFY21); Net Profit Up 12.3% (Quarterly Result Update)

Oct 22, 2020 | Updated on Oct 22, 2020

For the quarter ended September 2020, COLGATE has posted a net profit of Rs 3 bn (up 12.3% YoY). Sales on the other hand came in at Rs 13 bn (up 6.0% YoY). Read on for a complete analysis of COLGATE's quarterly results.

COLGATE Announces Quarterly Results (1QFY21); Net Profit Up 17.2% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, COLGATE has posted a net profit of Rs 2 bn (up 17.2% YoY). Sales on the other hand came in at Rs 10 bn (down 4.7% YoY). Read on for a complete analysis of COLGATE's quarterly results.

COLGATE 2018-19 Annual Report Analysis (Annual Result Update)

Sep 30, 2019 | Updated on Sep 30, 2019

Here's an analysis of the annual report of COLGATE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of COLGATE. Also includes updates on the valuation of COLGATE.

More Views on News

Most Popular

This One Smallcap Stock is a Must Have in Your Portfolio (Profit Hunter)

Nov 11, 2020

Investing in this smallcap could open doors of huge, long-lasting wealth.

This Diwali Consider Richa's #1 Stock Pick for 2021 (Profit Hunter)

Nov 13, 2020

Why I admire the approach that Richa uses to zero in on stocks with huge upside potential.

Should You Buy Gold Now? (Fast Profits Daily)

Nov 11, 2020

Pfizer has announced a vaccine for covid-19. In response, gold prices have fallen. Should you buy? Find out in this video..

Don't Let Brokerages Fool You into Buying HUL & Nestle. The Real Money is in These Stocks Right Now... Views On News (Views On News)

Nov 12, 2020

Rahul Shah discusses why he preferred a little known stock over Nestle Ltd and how he was proven right.

US Elections: Won a Battle, Now the War (The Honest Truth)

Nov 13, 2020

Ajit Dayal on the urgent need to fix the disparity between the rich and the poor in the US.


Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms


Nov 24, 2020 03:36 PM


  • Track your investment in COLGATE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks